Juvenile-onset recurrent respiratory papillomatosis (JORRP)- Monitoring Juvenile Onset Recurrent Respir

The Centers for Disease Control and Prevention is forecasting a future procurement focused on monitoring juvenile-onset recurrent respiratory papillomatosis, a rare disease characterized by the growth of noncancerous tumors in the respiratory tract of children. This initiative aims to enhance surveillance and data collection efforts to better understand disease patterns, treatment outcomes, and long-term impacts, with the goal of improving clinical management and public health responses. The effort is categorized under NAICS code 541715, indicating it involves research and development in the physical, engineering, and life sciences. The procurement will be managed by the CDC’s office, with Cynthia Brown serving as the program point of contact and a contracting officer to be named at a later date. All communications should be directed to ctt9@cdc.gov. The opportunity is currently in the forecast phase, meaning no formal solicitation has been issued, and potential vendors should prepare for future bidding based on anticipated requirements related to monitoring systems, data analysis, and possibly patient outcome tracking. There is no set-aside designation at this time, and the place of performance details have not been specified. Stakeholders should monitor the provided link for updates as the opportunity progresses toward a formal solicitation in 2026.